Cabilatazan, Ricky C.
HRN: 25-51-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/27/2024
08/31/2024
ORAL
500mg
Daily
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes